Successful Management of Voriconazole-Associated Hyponatremia with Therapeutic Drug Monitoring

Voriconazole is a broad-spectrum triazole antifungal agent and the first-choice therapy for invasive aspergillosis (IA) ([1][1]). Although voriconazole is generally well tolerated, anecdotal case reports have described unexpected severe adverse events related to voriconazole, such as hyponatremia,